# Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty

> **NCT03070847** · PHASE4 · UNKNOWN · sponsor: **Bartłomiej Wódarski** · enrollment: 50 (estimated)

## Conditions studied

- Bleeding Reduction

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Tranexamic Acid
- **DRUG:** Sodium Chloride

## Key facts

- **NCT ID:** NCT03070847
- **Lead sponsor:** Bartłomiej Wódarski
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2019-03
- **Final completion:** 2019-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070847, "Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03070847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*